These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 32314495)
1. Squalene epoxidase-induced cholesteryl ester accumulation promotes nasopharyngeal carcinoma development by activating PI3K/AKT signaling. Li L; Zhang Q; Wang X; Li Y; Xie H; Chen X Cancer Sci; 2020 Jul; 111(7):2275-2283. PubMed ID: 32314495 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of squalene epoxidase linking with PI3K/AKT signaling pathway suppresses endometrial cancer. Ma L; Huang W; Liang X; Bai G; Wang X; Jiang H; Xin Y; Hu L; Chen X; Liu C Cancer Sci; 2023 Sep; 114(9):3595-3607. PubMed ID: 37438885 [TBL] [Abstract][Full Text] [Related]
3. SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src/PI3K/Akt signaling pathway. Xu R; Song J; Ruze R; Chen Y; Yin X; Wang C; Zhao Y Cell Death Dis; 2023 Aug; 14(8):497. PubMed ID: 37542052 [TBL] [Abstract][Full Text] [Related]
4. Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target. Liu D; Wong CC; Fu L; Chen H; Zhao L; Li C; Zhou Y; Zhang Y; Xu W; Yang Y; Wu B; Cheng G; Lai PB; Wong N; Sung JJY; Yu J Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669855 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway. Huang Q; Hou S; Zhu X; Liu S World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999 [TBL] [Abstract][Full Text] [Related]
6. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro. Wang X; Jin Q; Wang X; Chen W; Cai Z Cancer Biomark; 2019; 26(2):171-182. PubMed ID: 31403940 [TBL] [Abstract][Full Text] [Related]
7. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway. Xie Z; Li W; Ai J; Xie J; Zhang X J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661 [TBL] [Abstract][Full Text] [Related]
8. The role and molecular mechanism of NOP16 in the pathogenesis of nasopharyngeal carcinoma. Xiong W; Li D; Ao F; Tu Z; Xiong J Cell Biochem Funct; 2024 Mar; 42(2):e3939. PubMed ID: 38454810 [TBL] [Abstract][Full Text] [Related]
9. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling. Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612 [TBL] [Abstract][Full Text] [Related]
10. ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling. Pan S; Liang S; Wang X Life Sci; 2021 Aug; 278():119581. PubMed ID: 33961854 [TBL] [Abstract][Full Text] [Related]
11. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts. Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682 [TBL] [Abstract][Full Text] [Related]
12. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma. Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308 [TBL] [Abstract][Full Text] [Related]
13. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway. Xie X; Xiong G; Chen W; Fu H; Li M; Cui X Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973 [TBL] [Abstract][Full Text] [Related]
14. Squalene epoxidase (SQLE) promotes the growth and migration of the hepatocellular carcinoma cells. Sui Z; Zhou J; Cheng Z; Lu P Tumour Biol; 2015 Aug; 36(8):6173-9. PubMed ID: 25787749 [TBL] [Abstract][Full Text] [Related]
16. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway. Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418 [TBL] [Abstract][Full Text] [Related]
17. OSBPL2 deficiency upregulate SQLE expression increasing intracellular cholesterol and cholesteryl ester by AMPK/SP1 and SREBF2 signalling pathway. Zhang C; Zhang H; Zhang M; Lin C; Wang H; Yao J; Wei Q; Lu Y; Chen Z; Xing G; Cao X Exp Cell Res; 2019 Oct; 383(2):111512. PubMed ID: 31356817 [TBL] [Abstract][Full Text] [Related]
18. Acylglycerol kinase promotes the stemness of nasopharyngeal carcinoma cells by promoting β-catenin translocation to the nucleus through activating PI3K/Akt pathway. Zhao Q; Sun P; Qin S; Liu J Environ Toxicol; 2020 Dec; 35(12):1299-1307. PubMed ID: 32652857 [TBL] [Abstract][Full Text] [Related]
19. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway. Wang B; Gu Q; Li J Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035 [TBL] [Abstract][Full Text] [Related]
20. Influences of S100A8 and S100A9 on Proliferation of Nasopharyngeal Carcinoma Cells through PI3K/Akt Signaling Pathway. Wen L; Ding Y; Chen X; Tian K; Li D; Liang K; Yue B Biomed Res Int; 2021; 2021():9917365. PubMed ID: 34604387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]